Literature DB >> 7380924

Rapid high-performance liquid chromatographic method for the measurement of amiodarone in blood plasma or serum at the concentrations attained during therapy.

R J Flanagan, G C Storey, D W Holt.   

Abstract

A simple high-performance liquid chromatographic method has been developed for the measurement of the antiarrhythmic drug amiodarone in small (200 microliter) volumes of plasma or serum. After addition of 2 mole/l phosphate solution, pH 4.5 (20 microliter), containing the internal standard, the sample is vortex-mixed with diisopropyl ether (200 microliter) for 30 sec. A portion (100 microliter) of the resulting extract is analysed on a microparticulate (5 micron) silica column using methanol-diethyl ether (85:15) containing perchloric acid (0.02% v/v) as the mobile phase, and the absorption of the column effluent is monitored at 240 nm. No endogenous sources of interference have been observed, and interference from other drugs is minimal. The procedure is rapid, an analysis in duplicate taking less than 15 min to complete. The limit of sensitivity of the assay is 0.05 mg/l, and the concentrations of amiodarone measured in plasma samples from patients under treatment with this compound ranged from 0.15 to 4.5 mg/l.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7380924     DOI: 10.1016/s0021-9673(00)80471-9

Source DB:  PubMed          Journal:  J Chromatogr


  13 in total

1.  Determination of amiodarone hydrochloride in pharmaceutical formulations by derivative UV spectrophotometry and high-performance liquid chromatography (HPLC).

Authors:  A M Di Pietra; V Cavrini; R Gatti; M A Raggi
Journal:  Pharm Res       Date:  1988-11       Impact factor: 4.200

2.  Use of amiodarone and digoxin specific Fab antibodies in digoxin overdosage.

Authors:  D P Nicholls; J G Murtagh; D W Holt
Journal:  Br Heart J       Date:  1985-04

3.  Renal elimination of amiodarone and its desethyl metabolite.

Authors:  L Harris; C R Hind; W J McKenna; C Savage; S J Krikler; G C Storey; D W Holt
Journal:  Postgrad Med J       Date:  1983-07       Impact factor: 2.401

Review 4.  New antiarrhythmic drugs: their place in therapy.

Authors:  D L Keefe; R E Kates; D C Harrison
Journal:  Drugs       Date:  1981-11       Impact factor: 9.546

5.  Prospective study of the potentiation of acenocoumarol by amiodarone.

Authors:  C Richard; B Riou; A Berdeaux; C Fournier; D Khayat; A Rimailho; J F Giudicelli; P Auzépy
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

6.  Pharmacokinetics of amiodarone after intravenous and oral administration.

Authors:  F Andreasen; H Agerbaek; P Bjerregaard; H Gøtzsche
Journal:  Eur J Clin Pharmacol       Date:  1981-03       Impact factor: 2.953

Review 7.  Clinical pharmacokinetics of amiodarone.

Authors:  R Latini; G Tognoni; R E Kates
Journal:  Clin Pharmacokinet       Date:  1984 Mar-Apr       Impact factor: 6.447

Review 8.  Clinical pharmacokinetics of the newer antiarrhythmic agents.

Authors:  A M Gillis; R E Kates
Journal:  Clin Pharmacokinet       Date:  1984 Sep-Oct       Impact factor: 6.447

9.  The QT interval: a predictor of the plasma and myocardial concentrations of amiodarone.

Authors:  N M Debbas; C du Cailar; R S Bexton; J G Demaille; A J Camm; P Puech
Journal:  Br Heart J       Date:  1984-03

10.  Transient neonatal hypothyroidism after gestational exposure to amiodarone: a follow-up of two cases.

Authors:  S Grosso; R Berardi; M Cioni; G Morgese
Journal:  J Endocrinol Invest       Date:  1998-11       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.